Shockwave Medical(@ShockwaveIVL):SKYWARD is off and running! Johnson & Johnson announced today the initiation of its SKYWARD IDE clinical program evaluating the novel Shockwave SkyRunner Carotid IVL System for the treatment of calcified carotid arteries prior to stenting. This clinical program is part of Johnson & Johnson’s plan to enhance treatment options for patients with calcified carotid artery disease, which accounts for up to one-third of all strokes. Read the Press Release: https://t.co/gBRY8HDsBj @JNJNews @JNJMedTech @NickMouawadMD CAUTION - Investigational device. Limited by US law to investigational use.

2026.06.25 12:01

SKYWARD is off and running! Johnson & Johnson announced today the initiation of its SKYWARD IDE clinical program evaluating the novel Shockwave SkyRunner Carotid IVL System for the treatment of calcified carotid arteries prior to stenting. This clinical program is part of Johnson & Johnson’s plan to enhance treatment options for patients with calcified carotid artery disease, which accounts for up to one-third of all strokes. Read the Press Release: @JNJNews @JNJMedTech @NickMouawadMD CAUTION - Investigational device. Limited by US law to investigational use.